Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia
Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia have?
Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia has 78 citations in the OpenAlex counts ScholarIQ stores.
When was Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia published?
Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia has 2019 year in the ScholarIQ index.
What is the open-access status of Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia?
Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia has gold oa status in the ScholarIQ index.
What is the DOI of Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia?
The DOI for Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia is on the source record.
What is the PMID of Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia?
The PMID for Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia is on the source record.
What is the OpenAlex record for Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia?
The OpenAlex for Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia is on the source record.